Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)

NCT02006732 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

809

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: olodaterol
DRUG: tiotropium
DRUG: placebo

Sponsor

Boehringer Ingelheim